IN8bio, Inc. Common Stock Share Price
NASDAQ: INABHealthcare
Live IN8bio, Inc. Common Stock Share Price Chart
O H L
IN8bio, Inc. Common Stock Performance Overview
Days Range
▼
$1.05Low
$1.05High
Markets Today
| Previous Close | $1.07 |
|---|---|
| Open | $1.05 |
| Volume | 2,960 |
| Day's Range | $1.05 - $1.05 |
| 52W Range | $0.88 - $2.73 |
| Market Cap | $9.96 M |
Historical Performance
| 1M Returns | -6.14 |
|---|---|
| 3M Returns | -25.17 |
| 6M Returns | -41.85 |
| 1Y Returns | -48.06 |
| 5Y Returns | -99.49 |
| 10Y Returns | NA |
IN8bio, Inc. Common Stock Fundamentals
| Market Cap | $9.96 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.92 |
| EPS TTM | $-2.05 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.54 |
| EBITDA | $-18.86 M |
| Profit Margin | N/A |
| Market Cap | $9.96 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.92 |
| EPS TTM | $-2.05 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.54 |
| EBITDA | $-18.86 M |
| Profit Margin | N/A |
IN8bio, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$5.66 M | -$5.20 M | -$3.97 M | -$5.03 M | -$5.27 M | -$4.93 M |
| EBITDA | -$5.40 M | -$4.95 M | -$3.72 M | -$4.79 M | -$5.02 M | -$4.68 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $256.00 K | $255.00 K | $244.00 K | $245.00 K | $245.00 K | $255.00 K |
| Income Before Tax | -$5.55 M | -$5.09 M | -$3.85 M | -$4.94 M | -$5.09 M | -$4.78 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$5.55 M | -$5.09 M | -$3.85 M | -$4.94 M | -$5.09 M | -$4.78 M |
| Net Profit Margin | - | - | - | - | - | - |
IN8bio, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $8.00 K | $10.00 K | $10.00 K | $10.00 K | $10.00 K | $10.00 K |
| Reserve & Surplus | -$127.21 M | -$132.30 M | -$136.15 M | -$141.10 M | -$146.19 M | -$150.97 M |
| Non-Current Liabilities | $3.04 M | $2.18 M | $1.88 M | $1.56 M | $1.33 M | $1.13 M |
| Current Liabilities | $2.96 M | $1.95 M | $1.70 M | $3.16 M | $2.16 M | $2.25 M |
| Total Liabilities | $5.99 M | $4.13 M | $3.58 M | $4.72 M | $3.48 M | $3.38 M |
| Fixed Assets | $2.60 M | $2.35 M | $2.10 M | $1.86 M | $1.62 M | $1.60 M |
| Current Assets | $12.72 M | $13.74 M | $11.77 M | $27.88 M | $22.66 M | $18.50 M |
| Total Assets | $19.87 M | $19.37 M | $16.77 M | $32.28 M | $26.27 M | $21.75 M |
IN8bio, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$5.55 M | -$5.09 M | -$3.85 M | -$4.94 M | -$5.09 M | -$4.78 M |
| Operating Cash Flow | -$3.12 M | -$3.93 M | -$3.52 M | -$2.14 M | -$4.95 M | -$3.75 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | -$9.00 K | -$233.00 K |
| Financing Cash Flow | $3.89 M | $5.27 M | $989.00 K | $18.49 M | -$195.00 K | -$51.00 K |
| Change in Cash | $771.00 K | $1.34 M | -$2.54 M | $16.35 M | -$5.15 M | -$4.03 M |
IN8bio, Inc. Common Stock Return Calculator
The IN8bio, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$50
Invested Amount$10,000
Est. Returns$-9,950
About IN8bio, Inc. Common Stock
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
Popular Stocks
FAQs
What is the share price of IN8bio, Inc. Common Stock today?
IN8bio, Inc. Common Stock (INAB) share price as of September 18, 2026 is $1.04. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of IN8bio, Inc. Common Stock?
Yes, Indian Investors can invest in the IN8bio, Inc. Common Stock (INAB) Share by opening an international trading account with Angel One.
How can I purchase IN8bio, Inc. Common Stock shares in India?
Purchasing IN8bio, Inc. Common Stock (INAB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying IN8bio, Inc. Common Stock (INAB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of IN8bio, Inc. Common Stock?
Yes, you can purchase fractional shares of IN8bio, Inc. Common Stock (INAB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of IN8bio, Inc. Common Stock?
The market capitalization of IN8bio, Inc. Common Stock on September 18, 2026, is $9.96 M.
In which sector IN8bio, Inc. Common Stock belongs?
IN8bio, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in IN8bio, Inc. Common Stock stocks?
In order to invest in IN8bio, Inc. Common Stock (INAB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
